Document Detail


Multiple-dose methotrexate for pregnancy in a cesarean section scar. A case report.
MedLine Citation:
PMID:  12012889     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Pregnancy developing in a cesarean section scar is a very rare but possibly life-threatening condition because of the risk of rupture and excessive hemorrhage. CASE: A woman with previous cesarean section had transvaginal sonography performed at 7 weeks of gestation that showed a gestational sac implanted in the anterior isthmus wall of the uterus with 3 mm of myometrium between the sac and bladder wall. A diagnosis of pregnancy in the cesarean section scar was made. The patient was asymptomatic, and her hemodynamic condition was stable. Two courses of multiple-dose systemic methotrexate-folinic acid (1 mg/kg methotrexate intramuscularly on days 1, 3, 5 and 7 with 0.1 mg/kg folinic acid intramuscularly on days 2, 4, 6 and 8) were given. The patient tolerated it and remained stable during treatment. The serum hCG dropped to < 5 IU/L on day 56. CONCLUSION: Treatment with methotrexate is a non-surgical option that can improve preservation of the uterus in patients who desire fertility. A multiple-dose regimen causes rapid interruption of the pregnancy. This is very important because the risk of rupture and hemorrhage directly correlates with the duration of the pregnancy.
Authors:
Po Mui Lam; Keith Wing Kit Lo
Related Documents :
21820259 - Cervical ectopic pregnancy diagnosed by point-of-care emergency department ultrasound.
2677359 - Successful treatment of a live cervical pregnancy with methotrexate and folinic acid. a...
9050729 - Clinical and financial analyses of ectopic pregnancy management at a large health plan.
24450299 - Microbial load of umbilical cord blood ureaplasma species and mycoplasma hominis in pre...
12797089 - Ectopic pregnancy treatment using pelviscopic or vaginosonographically-guided intrachor...
8527959 - Heterotopic pregnancies after controlled ovarian hyperstimulation and assisted reproduc...
11199209 - Reproductive efficiency of cows with endometritis after treatment with intrauterine inf...
23169109 - Correction of first trimester biochemical aneuploidy screening markers for smoking stat...
6189399 - Beta-subunit of human chorionic gonadotropin, ultrasound, and ectopic pregnancy: a pros...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  The Journal of reproductive medicine     Volume:  47     ISSN:  0024-7758     ISO Abbreviation:  J Reprod Med     Publication Date:  2002 Apr 
Date Detail:
Created Date:  2002-05-15     Completed Date:  2002-11-13     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0173343     Medline TA:  J Reprod Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  332-4     Citation Subset:  IM    
Affiliation:
Department of Obstetrics and Gynaecology, Prince of Wales Hospital, Chinese University of Hong Kong, Shatin, Hong Kong. lampomui@cuhk.edu.hk
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Abortifacient Agents, Nonsteroidal / administration & dosage*,  therapeutic use*
Adult
Cesarean Section / adverse effects*
Cicatrix / etiology*,  ultrasonography
Dose-Response Relationship, Drug
Female
Humans
Methotrexate / administration & dosage*,  therapeutic use*
Pregnancy
Pregnancy, Ectopic / drug therapy*,  ultrasonography
Chemical
Reg. No./Substance:
0/Abortifacient Agents, Nonsteroidal; 59-05-2/Methotrexate

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Ovarian stone. A case report.
Next Document:  Fleeing is no longer possible. The advice concerning dementia from the Health Council